In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Challenges in contemporary management of coronary artery disease
Session

Event : ESC Congress 2019

Topic : Coronary Artery Disease (Chronic)

  • Session type : Moderated Posters
  • Date : 03 September 2019
  • Time : 12:05 - 12:55

7 presentations in this session

Use of risk score to identify lower and higher risk subsets among COMPASS-Eligible patients with stable CAD. Insights from the CLARIFY Registry

Event : ESC Congress 2019

  • Session : Challenges in contemporary management of coronary artery disease
  • Speaker : G Ducrocq (Paris,FR)

Ten-year trends and outcomes in cardiogenic shock related to first-time acute myocardial infarction: a nationwide population-based cohort study.

Event : ESC Congress 2019

  • Session : Challenges in contemporary management of coronary artery disease
  • Speaker : M Dam Lauridsen (Copenhagen Sc,DK)

Trends in hospitalised cardiac arrest outcomes over 25 years in Scotland

Event : ESC Congress 2019

  • Session : Challenges in contemporary management of coronary artery disease
  • Speaker : R Bing (Edinburgh,GB)

The NPAC score for predicting survival after incident acute myocardial infarction

Event : ESC Congress 2019

  • Session : Challenges in contemporary management of coronary artery disease
  • Speaker : KH Li (Newcastle Upon Tyne,GB)

Efficacy of lipid lowering therapy beyond statins to prevent cardiovascular events: A meta-analysis

Event : ESC Congress 2019

  • Session : Challenges in contemporary management of coronary artery disease
  • Speaker : I Dykun (Essen,DE)

Members get more

Join now
  • 1ESC Professional Members – access all resources from general ESC events 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are